Tag Archive: John M. Maris

Jan 9 2019

New Cancer Moonshot Grant Catalyzes Research for Immunotherapy in Childhood Cancer

Creating the opportunity for every child with cancer to enjoy a healthy life beyond their cancer experience is the dream for pediatric oncology researchers. New grants awarded by the National Cancer Institute Moonshot Initiative through a multi-institutional, collaborative group — the  Pediatric Immunotherapy Discovery and Development Network (PI-DDN) —  aim to bring this dream closer to reality by fundamentally changing our understanding of how to harness the power of the immune system to treat childhood cancers.

Read the rest of this entry >>

Mar 9 2018

Lung Stem Cells, 2021 Congress of the ISTH, Backseat Safety, Pan-Cancer Analysis, Gates Cambridge Scholarship

From the discovery of stem cells that multiply after a lung injury, to new data that advances how we think about (and treat) childhood cancer, our first roundup of March is packed with discovery. Read on to learn how our researchers stay at the forefront of pediatric science with a new study that expands what scientists know about the body’s extraordinary ability to regenerate, a pan-cancer project that distinguishes how cancer develops in children versus adults, and a handful of updates on what our investigators have in store for the near future.

Read the rest of this entry >>

Feb 26 2018

John Maris, MD, Receives National Cancer Institute Outstanding Investigator Award

Long before he entered medical school, John M. Maris, MD, pediatric oncologist and the recent recipient of the National Cancer Institute’s Outstanding Investigator Award, became captivated by the mysteries of neuroblastoma. A cancer of the peripheral (not brain) nervous system, neuroblastoma accounts for 7 percent of all childhood cancers and 15 percent of all childhood cancer deaths.

Read the rest of this entry >>

Dec 3 2015

Study Gives New Insights Into Genetic Predisposition to Neuroblastoma

NeuroblastomaPediatric oncology researchers have narrowed down a culprit in an aggressive form of the childhood cancer neuroblastoma that makes the disease progress once tumors form.

Read the rest of this entry >>